Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC

Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC

Bibliographic Details
Main Authors: Catherine Daniel, MD, PhD, Celine Callens, PharmD, PhD, Samia Melaabi, MD, Ivan Bieche, PharmD, PhD, Nicolas Girard, MD, PhD
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:JTO Clinical and Research Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364320301053

Internet

http://www.sciencedirect.com/science/article/pii/S2666364320301053

Similar Items